Visual acuity following intravitreal bevacizumab for macular edema associated with retinal vein occlusion

Abstract

To study prognostic factors for visual acuity (VA) after intravitreal bevacizumab injection (IVB) for macular edema (ME) associated with retinal vein occlusion (RVO), by evaluating the correlation between the final VA and VA at baseline and at 1, 3, and 6 months after the initial IVB. We studied retrospectively 79 eyes of 79 patients with ME secondary to… (More)
DOI: 10.1007/s10384-010-0878-x

Topics

11 Figures and Tables

Cite this paper

@article{Ota2010VisualAF, title={Visual acuity following intravitreal bevacizumab for macular edema associated with retinal vein occlusion}, author={Masafumi Ota and Akitaka Tsujikawa and Kazuaki Miyamoto and Atsushi Sakamoto and Tomoaki Murakami and Nagahisa Yoshimura}, journal={Japanese Journal of Ophthalmology}, year={2010}, volume={54}, pages={555-564} }